Thus, we carried out a meta-analysis of RCTs to evaluate efficacy (asthma exacerbation, lung function, life quality and rescue medication use) and safety (adverse events) of anti-IL-13 antibodies for uncontrolled asthma. The gene discussed is IL13; the disease is asthma.